Structural, cellular, and molecular evaluation of bone erosion in experimental models of rheumatoid arthritis: Assessment by μcT, histology, and serum biomarkers

Autoimmunity

Volumn 43, Issue 8, 2010, Pages 642-653

  Chao, Cheng Chi ^a   Chen, Shi Juan ^a   Adamopoulos, Iannis E ^a   Judo, Michael ^a   Asio, Agelio ^a   Ayanoglu, Gulesi ^a   Bowman, Edward P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

adjuvant induced arthritis; anti IL 17; collagen induced arthritis; Micro computed tomography; RANKL

Indexed keywords

INTERLEUKIN 17 ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE EROSION; BONE REMODELING; BONE STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; DISEASE SEVERITY; HISTOPATHOLOGY; MALE; METATARSOPHALANGEAL JOINT; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOCLAST ACTIVITY; OSTEOLYSIS; RAT; RHEUMATOID ARTHRITIS; TARSAL BONE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BONE RESORPTION; FOOT; HISTOCYTOCHEMISTRY; INTERLEUKIN-17; MALE; MICE; RANK LIGAND; RATS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78149446588     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916931003610992     Document Type: Article

References (37)

1. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. Synovial tissue in rheumatoid arthritis is a source ofosteoclast differentiation factor. Arthritis Rheum 2000;43:250-258.
2. Katz Y, Nadiv O, Rapoport MJ, Loos M. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts. Clin Exp Immunol 2000; 120:22-29.
3. Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 1985;28:25-31.
4. Takayanagi H, Oda H, Yamamoto S, Kawaguchi H, Tanaka S, Nishikawa T, Koshihara Y. A new mechanism of bone destruction in rheumatoid arthritis: Synovial fibroblasts induce osteoclastogenesis. Biochem Biophys Res Commun 1997;240: 279-286.
5. Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci 1997;61:1861-1878.
6. Kannan K, Ortmann RA, Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 2005;12:167-181.
7. Herman S, Kronke G, Schett G. Molecular mechanisms of inflammatory bone damage: Emerging targets for therapy Trends Mol Med 2008;14:245-253.
8. Romas E, Gillespie MT. Inflammation-induced bone loss: Can it be prevented? Rheum Dis Clin North Am 2006;32: 759-773.
9. van den Berg WB, van Lent PL, Joosten LA, Abdollahi-Roodsaz S, Koenders MI. Amplifying elements of arthritis and joint destruction. Ann Rheum Dis 2007;66(Suppl 3): iii45-iii48.
10. Adamopoulos IE, Sabokbar A, Wordsworth BP, Carr A, Ferguson DJ, Athanasou NA. Synovial fluid macrophages are capable ofosteoclast formation and resorption. J Pathol 2006; 208:35-43.
11. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93:165-176.
12. Stolina M, Adamu S, Ominsky M, Dwyer D, Asuncion F, Geng Z, et al. RANKL is a marker and mediator of local and systemic bone loss in two rat models ofinflammatory arthritis. J Bone Miner Res 2005;20:1756-1765.
13. Ziolkowska M, Kurowska M, Radzikowska A, Luszczykiewicz G, Wiland P, Dziewczopolski W, et al. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. Arthritis Rheum 2002;46:1744-1753.
14. Schett G, Hayer S, Zwerina J, Redlich K, Smolen JS. Mechanisms of disease: The link between RANKL and arthritic bone disease. Nat Clin Pract Rheumatol 2005;1: 47-54.
15. Silva MD, Savinainen A, Kapadia R, Ruan J, Siebert E, Avitahl N, et al. Quantitative analysis of micro-CT imaging and histopathological signatures of experimental arthritis in rats. Mol Imag 2004;3:312-318.
16. Martin-Badosa E, Amblard D, Nuzzo S, Elmoutaouakkil A, Vico L, Peyrin F. Excised bone structures in mice: Imaging at three-dimensional synchrotron radiation micro CT. Radiology 2003;229:921-928.
17. Barck KH, Lee WP, Diehl LJ, Ross J, Gribling P, Zhang Y, et al. Quantification of cortical bone loss and repair for therapeutic evaluation in collagen-induced arthritis, by micro-computed tomography and automated image analysis. Arthritis Rheum 2004;50:3377-3386.
18. Nishida S, Tsurukami H, Sakai A, Sakata T, Ikeda S, Tanaka M, et al. Stage-dependent changes in trabecular bone turnover and osteogenic capacity of marrow cells during development of type II collagen-induced arthritis in mice. Bone 2002;30:872-879.
19. Barbier A, Martel C, de Vernejoul MC, Tirode F, Nys M, Mocaer G, et al. The visualization and evaluation of bone architecture in the rat using three-dimensional X-ray microcomputed tomography. J Bone Miner Metab 1999;17: 37-44.
20. Balto K, Muller R, Carrington DC, Dobeck J, Stashenko P. Quantification of periapical bone destruction in mice by micro-computed tomography. J Dent Res 2000;79:35-40.
21. Hwang SY, Kim HY. Expression ofIL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells 2005;19:180-184.
22. Honorati MC, Meliconi R, Pulsatelli L, Cane S, Frizziero L, Facchini A. High in vivo expression ofinterleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology (Oxford) 2001;40:522-527.
23. Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL, et al. Association ofinterleukin-18 expression with enhanced levels ofboth interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2003;48:339-347.
24. Page G, Sattler A, Kersten S, Thiel A, Radbruch A, Miossec P. Plasma cell-like morphology ofTh1-cytokine-producing cells associated with the loss of CD3 expression. Am J Pathol 2004; 164:409-417.
25. Aarvak T, Chabaud M, Miossec P, Natvig JB. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 1999;162:1246-1251.
26. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, et al. High levels ofIL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000;164:2832-2838.
27. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963-970.
28. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteo-clastogenesis. J Clin Invest 1999;103:1345-1352.
29. Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Di Padova FE, et al. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol 2005;167:141-149.
30. van den Berg WB, Miossec P. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 2009; 5: 549-553.
31. Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: Lessons from animal models. Arthritis Res Ther 2005;7: 29-37.
32. Xing L, Schwarz EM, Boyce BF. Osteoclast precursors, RANKL/RANK, and immunology. Immunol Rev 2005;208: 19-29.
33. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994;53:39-44.
34. Fujikawa Y, Sabokbar A, Neale S, Athanasou NA. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis 1996;55:816-822.
35. Itonaga I, Fujikawa Y, Sabokbar A, Murray DW, Athanasou NA. Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent. JPathol 2000;192:97-104.
36. Danks L, Sabokbar A, Gundle R, Athanasou NA. Synovial macrophage-osteoclast differentiation in inflammatory arthri-tis. Ann Rheum Dis 2002;61:916-921.
37. Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T The molecular mechanism of osteoclastogenesis in rheuma-toid arthritis. Arthritis Res 2002;4:281-289.